Opthea Limited

Opthea Limitedverified

OPT

Price:

$3.41

Market Cap:

$580.47M

Opthea Limited is an Australian biopharmaceutical company operating at the clinical development stage, focused on discovering and commercializing treatments primarily for ophthalmic conditions. Its research and development efforts are underpinned by an intellectual property portfolio that covers Vascular Endothelial Growth Factors (VEGF) C and D, along with VEGF Receptor-3. This proprietary foundation targets diseases stemming from abnormal blood and lymphatic vessel growth or vascular leakage. The company's primary therapeutic candidate, OPT 302, is a soluble form of VEGFR-3 currently undergoing clinical evaluation. This novel agent is being developed for treating wet neovascular age-relate...[Read more]

Industry

Biotechnology

IPO Date

2020-10-16

Stock Exchange

NASDAQ

Ticker

OPT

The Enterprise Value as of June 2026 (TTM) for Opthea Limited (OPT) is 778.12M

According to Opthea Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 778.12M. This represents a change of 33.32% compared to the average of 583.65M of the last 4 quarters.

Opthea Limited (OPT) Historical Enterprise Value (quarterly & annually)

How has OPT Enterprise Value performed in the past?

The mean historical Enterprise Value of Opthea Limited over the last ten years is 265.49M. The current 778.12M Enterprise Value has changed 29.21% with respect to the historical average. Over the past ten years (40 quarters), OPT's Enterprise Value was at its highest in in the December 2024 quarter at 1.01B. The Enterprise Value was at its lowest in in the December 2014 quarter at -9002416.46.

Quarterly (TTM)
Annual

Average

265.49M

Median

199.73M

Minimum

70.25M

Maximum

686.38M

Opthea Limited (OPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Opthea Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 896.88%

Maximum Annual Enterprise Value = 686.38M

Minimum Annual Increase = -46.10%

Minimum Annual Enterprise Value = 70.25M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025686.38M262.48%
2024189.36M-9.88%
2023210.11M-39.16%
2022345.33M15.82%
2021298.17M-46.10%
2020553.15M340.77%
2019125.50M40.41%
201889.38M2.37%
201787.31M24.28%
201670.25M896.88%

Opthea Limited (OPT) Average Enterprise Value

How has OPT Enterprise Value performed in the past?

The current Enterprise Value of Opthea Limited (OPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

361.95M

5-year avg

345.87M

10-year avg

265.49M

Opthea Limited (OPT) Enterprise Value vs. Peers

How is OPT’s Enterprise Value compared to its peers?

Opthea Limited’s Enterprise Value is less than Mirati Therapeutics, Inc. (3.93B), less than Alpine Immune Sciences, Inc. (4.42B), less than RayzeBio, Inc. Common Stock (3.63B), less than CymaBay Therapeutics, Inc. (3.64B), less than SpringWorks Therapeutics, Inc. (3.48B), less than IVERIC bio, Inc. (5.13B), less than Syneos Health, Inc. (7.24B), less than MorphoSys AG (2.94B), less than Morphic Holding, Inc. (2.81B), greater than Abcam plc (134.60M),

Build a custom stock screener for Opthea Limited (OPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opthea Limited (OPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Opthea Limited's Enterprise Value?

What is the highest Enterprise Value for Opthea Limited (OPT)?

What is the 3-year average Enterprise Value for Opthea Limited (OPT)?

What is the 5-year average Enterprise Value for Opthea Limited (OPT)?

How does the current Enterprise Value for Opthea Limited (OPT) compare to its historical average?